Cargando…
Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion
The anti-diabetic metformin has been demonstrated to be effective in suppression of tumor progression via multiple mechanisms, in which angiogenic inhibition is involved. Hypoxia is a common feather of malignant tumor and promotes angiogenesis via induction of pro-angiogenic factors. However, the ef...
Autores principales: | Wang, Ji-Chang, Li, Guang-Yue, Li, Ping-Ping, Sun, Xin, Li, Wei-Ming, Li, Yan, Lu, Shao-Ying, Liu, Pei-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650310/ https://www.ncbi.nlm.nih.gov/pubmed/29088755 http://dx.doi.org/10.18632/oncotarget.18029 |
Ejemplares similares
-
Metformin and simvastatin synergistically suppress endothelin 1‐induced hypoxia and angiogenesis in multiple cancer types
por: Liu, Jie, et al.
Publicado: (2022) -
Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo
por: Han, Jing, et al.
Publicado: (2018) -
JSI-124 Suppresses Invasion and Angiogenesis of Glioblastoma Cells In Vitro
por: Yuan, Guang, et al.
Publicado: (2015) -
Evodiamine inhibits vasculogenic mimicry in HCT116 cells by suppressing hypoxia-inducible factor 1-alpha-mediated angiogenesis
por: Zeng, Di, et al.
Publicado: (2021) -
Metformin: The next angiogenesis panacea?
por: Ren, Yu, et al.
Publicado: (2021)